With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

Salesforce, the U.S.-based software giant, revealed plans for a $500 million investment in Saudi Arabia, aimed at fueling the country’s AI sector and driving economic growth. The announcement was made on the first day of the LEAP 2025 tech conference in Riyadh.

As part of the expansion, Salesforce will launch its Hyperforce platform, in partnership with Amazon Web Services (AWS). This next-generation platform allows global customers to run workloads locally through a distributed public cloud infrastructure in Saudi Arabia.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

In addition to technological innovation, Salesforce aims to upskill 30,000 Saudi nationals in AI and promote women’s participation in the workforce. The company is partnering with Princess Nourah University (PNU), the world’s largest women’s university, to provide AI-focused learning opportunities and workforce development for female students.

This investment aligns with Salesforce’s pledge at the Davos conference to expand its presence in the region, including the establishment of a new regional headquarters in Riyadh.

Growing Demand For AI In Saudi Arabia

The increasing adoption of Salesforce’s AI-powered digital labor platform, Agentforce, by businesses in Saudi Arabia signals a growing demand for AI-driven solutions. The company is also collaborating with key partners like Capgemini, Deloitte, Globant, IBM, and PwC to support digital growth in the country.

On the opening day of LEAP 2025, Saudi Arabia secured $14.9 billion in tech investments, further solidifying its position as a hub for digital innovation.

Salesforce stock rose by 1.4%, closing at $327.2 per share on February 10, 2025, with a market capitalization of $313.1 billion. The company ranks 158th on the Forbes 2024 Global 2000 list.

Groq, a U.S.-based AI semiconductor startup, has secured a $1.5 billion commitment from Saudi Arabia to expand its advanced AI chip delivery in the country. The startup, founded by a former Alphabet AI chip engineer, specializes in AI inference chips that optimize speed and execute commands for pre-trained models.

Groq already has a partnership with Aramco Digital, the tech arm of oil giant Aramco, through which they developed a key AI hub in the region in December. The investment will fund the expansion of Groq’s data center in Dammam, with the startup having obtained the necessary licenses to export its chips despite U.S. export controls.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The announcement was made at Saudi Arabia’s LEAP 2025 event, where the country also secured $14.9 billion in AI investments. One of the technologies supported by the Dammam Center is Allam, an AI language model developed by the Saudi government that operates in both Arabic and English.

In August, Groq raised $640 million in a funding round led by Cisco, Samsung, and BlackRock, bringing its valuation to $2.8 billion.

U.S. Vice President JD Vance warned European leaders on Tuesday that excessive regulation of AI could hinder its growth. He also criticized content moderation as “authoritarian censorship.” As AI evolves, the focus has shifted from safety concerns to geopolitical competition, with nations vying to lead the field.

At an AI summit in Paris, Vance affirmed that the U.S. intends to remain the AI leader, opposing the European Union’s stricter regulatory approach.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Key Takeaways

• Excessive regulation may harm AI: Vance cautioned that heavy regulations could stifle AI innovation.
• AI must remain free from bias: He emphasized that U.S. AI should not be used for authoritarian purposes.
• GDPR compliance costs: Vance pointed to high compliance costs in Europe, especially for smaller companies.
• U.S. supports fair competition: Vance affirmed that U.S. laws ensure a level playing field for all developers.

Vance warned that excessive regulation could stifle innovation, arguing that AI should remain free from ideological bias and not be used for authoritarian censorship. He criticized Europe’s GDPR for increasing legal costs for small firms and cautioned that stringent safety regulations could solidify the dominance of large tech companies, hindering new competitors. 

While the U.S. supports fair competition in AI, Vance emphasized that laws should prevent the entrenchment of market power. In contrast, European lawmakers passed the AI Act, facing pressure for lenient enforcement. French President Macron called for reduced red tape to boost AI growth, highlighting the growing divide in AI regulation between the U.S., China, and Europe. Vance leads the U.S. delegation at the summit, where nearly 100 countries, including China, India, and the U.S., are seeking common ground on AI policy.

French wine and spirits exports experienced a second consecutive year of decline in 2024, as demand for premium products dropped and the industry grappled with lower prices, a softer Chinese market, and potential tariff threats, according to the Federation of Wine and Spirits Exporters (FEVS).

Key Essentials

• Total exports: €15.6 billion ($17.5 billion), a 4% drop from 2023.
• Volume: Steady at 174 million cases, but value hit hard in key markets, particularly in China.
• China’s imports: Down 20%, accounting for the largest portion of the decline. Other markets like Singapore and Hong Kong also saw decreases of 25% and 12%, respectively, making up 90% of the overall drop.

French spirits exports were especially affected, falling 6.5% to €4.5 billion. This decline was largely attributed to China’s economic struggles and Beijing’s anti-dumping measures on European brandy, especially French cognac. Sales of cognac saw an 11% drop in value, although the volume only decreased by 1%, supported by restocking in the United States and precautionary purchases in light of fears of new U.S. tariffs on French wine.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The gap between the decline in value and the slight drop in volume is believed to reflect a shift toward younger, less expensive cognac. While this trend has impacted the overall value, it has kept volumes relatively stable.

Exports to the United States, which remains France’s largest export market, showed more resilience, with a 5% increase to €3.8 billion. Despite this growth, the wine sector saw a 3% drop in revenue, totaling €10.9 billion, largely driven by an 8% decline in Champagne sales.

Looking ahead, FEVS Chairman Gabriel Picard highlighted two major uncertainties for the upcoming year: the situation in China and the potential impact of U.S. tariffs. While economic fundamentals in the U.S. appear relatively stable, there are concerns about future tax increases. Regarding China, Picard praised efforts to support the Cognac sector but called for “concrete action” to ease trade tensions ahead of a planned visit from Prime Minister François Bayrou.

Swiss pharmaceutical giant Novartis has struck a deal to acquire Anthos Therapeutics, a biopharma company majority-owned by Blackstone’s drug development arm, for up to $3.1 billion. The acquisition is aimed at bolstering Novartis’ presence in the cardiovascular sector, a key focus for the company as its blockbuster heart failure drug Entresto faces patent expiration this year.

Founded in 2019 by Blackstone’s Life Sciences division and Novartis, Anthos was created to develop abelacimab, a promising treatment designed to prevent strokes and prevent recurring blood clots. This transaction underscores Novartis’ commitment to cardiovascular treatments, which is one of five critical therapeutic areas the company is prioritizing.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The deal, which is expected to close by mid-2025, marks a significant step in the evolving partnership between a major pharmaceutical company and private equity, a model that has gained traction in the industry. Novartis will pay an initial $925 million, with potential additional payments up to $2.15 billion, contingent on the successful development of the therapy.

This marks the largest sale of a majority-owned company by Blackstone’s Life Sciences division to date. In December 2023, Blackstone was exploring the sale of Anthos, and the current deal brings the partnership to a close.

Abelacimab is part of a new class of anticoagulants known as factor XI inhibitors, designed to potentially replace established blood thinners like Eliquis (Bristol Myers-Squibb and Pfizer) and Xarelto (Johnson & Johnson and Bayer), both of which are billion-dollar sellers. Other major companies in the factor XI race include Bristol-Myers Squibb and Johnson & Johnson, who are advancing a similar drug candidate, as well as Merck & Co, which is progressing with a mid-stage development candidate. Bayer, meanwhile, faced a setback in 2023 with its factor XI drug.

Nicholas Galakatos, Chairman of Anthos’ board and Global Head of Blackstone Life Sciences expressed pride in the firm’s role in launching and growing Anthos, adding, “We believe abelacimab has the potential to be a leader in the new class of Factor XI anticoagulants and are pleased to have Novartis as a committed partner to advance the development and commercialization of abelacimab for millions of patients at risk of strokes.”

Anthos is currently conducting multiple Phase 3 clinical trials, with data expected in the second half of 2026. While Novartis holds a small minority equity stake in Anthos, the company has not disclosed the exact size of this investment.

The recent release of Deepseek’s artificial intelligence model has sent ripples through the tech world, with Demis Hassabis, CEO of Google DeepMind, calling it “probably China’s best work.” However, despite the accolades, he cautioned that the company hasn’t unveiled any groundbreaking scientific advancements.

Key Points to Know

In a move that stirred up global markets, Deepseek, a Chinese AI company, published a paper last month claiming its AI model was trained at a fraction of the cost of leading players like OpenAI and on less powerful Nvidia systems. This announcement ignited a significant market sell-off, raising questions about the massive investment tech giants are making in AI infrastructure.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Hassabis acknowledged the model’s impressive engineering, praising it as “probably the best work I’ve seen from China.” Speaking at an event in Paris before the AI Action Summit, Hassabis emphasized that while Deepseek’s achievement is noteworthy, it doesn’t represent any major technological leap. “It’s not a huge change from what we’ve seen before,” he remarked.

The Bigger Picture

Despite the media frenzy surrounding Deepseek, Hassabis stressed that there are no new scientific breakthroughs in the model, with the company relying on established AI techniques. “The hype is a bit exaggerated,” he added, pointing out that although the engineering is strong, there’s no fundamental shift in the technology.

Deepseek’s claims about its cost-efficiency and chip usage have been met with skepticism. Experts question whether the Chinese company’s development costs are as low as they suggest, with some analysts suspecting that the actual expenses could be much higher.

Looking Ahead: AGI On The Horizon

The industry has long debated when artificial general intelligence (AGI)—AI that exceeds human intelligence—will come to fruition. Hassabis believes we’re on the brink of achieving it, estimating that AGI could be just five years away. “We’re very close now,” he said. “It would be extraordinary, and society needs to be ready for it.”

While many industry leaders, including OpenAI CEO Sam Altman, share a sense of optimism about AGI’s imminent arrival, there are significant risks associated with its development. The idea of humans losing control over their creations remains a major concern, echoed by AI pioneers like Max Tegmark and Joshua Bengio.

The Road Ahead

As the AI race continues to heat up, Deepseek’s AI model has brought China into the conversation as a serious contender on the global stage. While the hype around the company may be inflated, its role in the shifting landscape of artificial intelligence cannot be ignored. The next few years will determine whether Deepseek’s advancements are just a stepping stone or the beginning of a truly transformative era in AI.

Elon Musk is at the forefront of a $97.4 billion bid to acquire the assets of the nonprofit that controls OpenAI, further intensifying his ongoing clash with OpenAI CEO Sam Altman. The group backing Musk’s bid includes Vy Capital, Xai (Musk’s AI company), Hollywood mogul Ari Emanuel, and other investors.

This move represents Musk’s latest attempt to take control of an organization he co-founded nearly a decade ago. However, the bid faces strong resistance, as OpenAI’s board is closely aligned with Altman, who swiftly dismissed Musk’s offer with a pointed remark: “No thank you but we will buy Twitter for $9.74 billion if you want.” Musk responded with a sharp “Swindler.”

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Despite the tense exchange, Musk’s offer complicates OpenAI’s plans to complete a $40 billion fundraising round, which would nearly double the company’s valuation to $300 billion. Led by SoftBank, this deal would position OpenAI among the world’s most valuable private companies, alongside Musk’s SpaceX and ByteDance, the parent company of TikTok.

OpenAI’s board of directors, which remains loyal to Altman, may need to deal with the complex challenge of compensating the nonprofit that controls OpenAI if they move ahead with Musk’s bid. OpenAI, with over 2,000 employees, is structured with a nonprofit board that has legal control despite its limited resources, with only two employees and $22 million in assets.

Musk’s bid could force OpenAI to pay a high price for separating from the nonprofit board, which has led to legal scrutiny. In the eyes of many experts, Musk’s proposal is an effort to set the nonprofit’s assets at a very high value, which would create challenges for OpenAI’s move to full independence. The nonprofit’s board must ensure that the sale of assets is at fair market value, or they could face questions from charity regulators.

Musk’s aggressive approach signals his intent to reshape the AI industry, with his own AI company, Xai, directly competing with OpenAI. At the same time, Altman has garnered significant support in Washington, securing investments and backing from major players like SoftBank and Oracle.

The ongoing battle for control of OpenAI illustrates the high stakes involved in the race for artificial intelligence supremacy, with Musk and Altman at the center of a high-profile tech showdown.

Norway is setting the standard for electric vehicle (EV) adoption worldwide. What was once a niche market has transformed into the norm, with EVs accounting for 88.9% of all car sales in 2024. Even more striking, in the first weeks of 2025, EVs made up over 96% of new cars sold, according to the Norwegian Public Roads Agency.

This progress brings Norway closer to its goal of 100% electric vehicle sales, a target originally set in 2017. 

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

A Blueprint For Success: Consistent Policies Drive Growth

Norway’s success can be attributed to consistent, long-term policies that foster the adoption of electric vehicles. Rather than enforcing prohibitive measures, Norway introduced a suite of incentives such as VAT exemptions, discounts on road and parking taxes, and even the ability to use bus lanes. The country has also heavily invested in public charging infrastructure, making EVs an increasingly viable option for citizens.

Norway’s Deputy Minister of Transport, Cecilie Knibbe Krogglund, refers to these changes as a “new normal” for the country’s 5.5 million residents. The government’s focus on electric mobility goes beyond passenger vehicles: it is set to switch to fully electric city buses by 2025 and aims for 75% of heavy commercial vehicles to be green by 2030.

A Different Landscape In Europe And The U.S.

Norway’s aggressive push to transition its fleet to electric vehicles stands in contrast to the more gradual changes in other regions. The European Union has legislated a ban on new carbon-emitting vehicles by 2035, while Britain aims to eliminate the sale of new petrol and diesel cars by 2030. In the U.S., however, electric vehicles accounted for just 8.1% of total car sales in 2024, a modest increase from 7.8% the year before, according to market research from Cox Automotive.

Norway’s strong performance is bolstered by its relatively low energy costs, driven by its status as a major oil and gas exporter. But not every country can match this advantage. Germany, for example, recently scrapped its EV subsidies, leading to a dip in sales. However, the country is considering tax breaks for electric cars in response to declining sales.

Norwegian Policies: A Global Example

Despite its role as an oil and gas producer, Norway’s electric vehicle policies have earned international praise. The future of EVs in Norway is bright, and the country plans to only sell “zero-emission” passenger cars by 2025, making it the world’s leader in EV adoption. For Norwegians like Harald Nils Rostvik, a professor at the University of Stavanger, the advantages of driving an electric car are undeniable. “They’re quieter, more economical, and cleaner. Plus, you don’t need to worry about oil filters or opening the hood.”

Norway’s commitment to sustainable mobility sets a high bar, showing how thoughtful policies and incentives can shift a nation’s automotive landscape in just over a decade.

Cyprus’s trade deficit has seen a modest reduction of 3.97% in 2024, dropping from €8,470.4 million in January–December 2023 to €8,134.3 million in the same period of 2024, according to provisional data from Cystat

Key Highlights:

• Imports: Total imports for 2024 were €12,256.1 million, down by 7% from 2023 (€13,179.8 million).
• Exports: Exports fell by 12.5% to €4,121.8 million, compared to €4,709.4 million in 2023.

December 2024 Snapshot

• Imports in December surged to €1,314.3 million, a significant increase of 37.8% from December 2023 (€954.1 million).
  • Imports from the EU: €662.7 million
  • Imports from third countries: €651.6 million
• Exports in December totaled €359 million, down by 8.5% from December 2023 (€392.4 million).
  • Exports to the EU: €88 million
  • Exports to third countries: €271 million

Noteworthy: December imports included a significant €372.5 million from vessel and aircraft ownership transfers—up dramatically from just €4.8 million in December 2023.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

November 2024 Recap

• Imports in November increased by 3.7%, reaching €1,139.6 million (compared to €1,098.6 million in November 2023).
• Domestic exports grew by 7.7%, totaling €244.1 million.
  • Industrial product exports were up to €236.5 million from €218.2 million in November 2023.
  • Agricultural exports remained steady at €6.5 million.

However, exports of foreign products plummeted by 74.2%, from €519.2 million in November 2023 to just €134.1 million in November 2024.